Journal profile · Multiple
Eurasian Journal of Medicine and Oncology
ISSN 2587-2400 · eISSN 2587-196X · Kare Publishing · TURKIYE · Quarterly · Founded 2017
Eurasian Journal of Medicine and Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; 160 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Eurasian Journal of Medicine and Oncology is published by Kare Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Immunotherapy and Biomarkers, SARS-CoV-2 and COVID-19 Research and Head and Neck Cancer Studies, together about 19.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Aim of the journal is to publish qualified research material on its scope. The target readership includes academic members or specialists on medicine and oncology. Scope of the journal covers medicine and oncology. EJMO publishes articles following a double-blind peer review mechanism to ensure the standards of its publications. EJMO selects generally from Reviewers situated in ScholarOne-Publons. The Eurasian Journal of Medicine and Oncology (EJMO) is published every three months (March, June, September, December)
Source: LetPub
Research area (LetPub): Multiple
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Immunotherapy and BiomarkersMedicine7.6%
- SARS-CoV-2 and COVID-19 ResearchMedicine5.9%
- Head and Neck Cancer StudiesMedicine5.7%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology5.2%
- COVID-19 Clinical Research StudiesMedicine5%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine5%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology5%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Internal Medicine | Q3 | 130/179 | 27th |
| Oncology | Q4 | 335/428 | 21st |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.1LetPub ·
- SJR 2026-06
- 0.24LetPub ·
- SNIP 2026-06
- 0.19LetPub ·
- h-index
- 18OpenAlex ·
- i10-index
- 34OpenAlex ·
- 2-year mean citedness
- 0.76OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 87.63%LetPub ·
Volume
- Articles per year
- 91LetPub ·
Articles by year OpenAlex count · 767 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 177 | 177 | 298 |
| 2025 | 160 | 160 | 236 |
| 2024 | 45 | 45 | 231 |
| 2023 | 52 | 52 | 347 |
| 2022 | 51 | 51 | 442 |
| 2021 | 45 | 45 | 604 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Kare Publishing
- Country or region
- TURKIYE
- Language
- English
- Frequency
- Quarterly
- Founded
- 2017
- ISSN
- 2587-2400
- Electronic ISSN
- 2587-196X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Eurasian Journal of Medicine and Oncology
What CAS zone is Eurasian Journal of Medicine and Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Eurasian Journal of Medicine and Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, General & Internal / Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
Which databases index Eurasian Journal of Medicine and Oncology?
According to LetPub and DOAJ records, Eurasian Journal of Medicine and Oncology is indexed in ESCI and Scopus.
Is Eurasian Journal of Medicine and Oncology open access, and what is the APC?
Eurasian Journal of Medicine and Oncology is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .